Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

THERMO FISHER SCIENTIFIC

(TMO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Thermo Fisher Scientific : Sets $3 Billion Share Buyback Program

09/23/2021 | 04:13pm EDT


ę MT Newswires 2021
All news about THERMO FISHER SCIENTIFIC
01:11pThermo Fisher set to benefit from demand for testing kits, vaccines
RE
08:06aA Letter From Our CEO On Corporate Social Responsibility
PU
08:01aThermo Fisher Scientific Publishes 2020 Corporate Social Responsibility Report
PR
10/22THERMO FISHER SCIENTIFIC INC. : Entry into a Material Definitive Agreement, Other Events, ..
AQ
10/20THERMO FISHER SCIENTIFIC : Citigroup Upgrades Thermo Fisher Scientific to Buy from Neutral..
MT
10/20THERMO FISHER SCIENTIFIC : Thinking about trading options or stock in Abbott Laboratories,..
PR
10/20Health Care Stocks Advance Pre-Bell Wednesday
MT
10/20THERMO FISHER SCIENTIFIC : Prices $5.85 Billion Offering of Senior Notes
MT
10/19THERMO FISHER SCIENTIFIC : Prices Offering of USD-Denominated Senior Notes
PR
10/19Thermo Fisher Scientific Inc. Prices Offering of USD-Denominated Senior Notes
CI
More news
Analyst Recommendations on THERMO FISHER SCIENTIFIC
More recommendations
Financials (USD)
Sales 2021 36 089 M - -
Net income 2021 7 158 M - -
Net Debt 2021 18 490 M - -
P/E ratio 2021 33,7x
Yield 2021 0,16%
Capitalization 239 B 239 B -
EV / Sales 2021 7,14x
EV / Sales 2022 6,53x
Nbr of Employees 80 000
Free-Float 89,6%
Chart THERMO FISHER SCIENTIFIC
Duration : Period :
Thermo Fisher Scientific Technical Analysis Chart | TMO | US8835561023 | MarketScreener
Technical analysis trends THERMO FISHER SCIENTIFIC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 21
Last Close Price 608,34 $
Average target price 646,50 $
Spread / Average Target 6,27%
EPS Revisions
Managers and Directors
Marc N. Casper Chairman, President & Chief Executive Officer
Stephen Williamson Chief Financial Officer & Senior Vice President
Ryan Snyder Chief Information Officer & Senior Vice President
Alan B. Sachs Chief Medical Officer
Karen E. Nelson Chief Scientific Officer
Sector and Competitors